According to Zhitong Finance App, Boan Biotech (06955.HK) issued an announcement. It is expected that the Group will obtain a net loss attributable to the company's equity holders of approximately RMB 79 million to RMB 89 million in the six months ending June 30, 2026 (reporting period), while the net profit attributable to the company's equity holders will be approximately RMB 21 million for the six months ending June 30, 2025.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.